EUVIMEDEUVIMED entdecken
Open Access

Impact of High Lymph Node Burden on Brain Metastases in Patients Who Achieved Pathological Complete Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Seung Ah Lee, Ki Jo Kim, Do Youn Woen, Su Min Lee, Kawon Oh, Cho Eun Lee, Woong Ki Park, Ji Won Yoo, Dong Seung Shin, Jai Min Ryu, Se Kyung Lee, Byung Joo Chae und 8 weitere

Cancer Research and Treatment · 2025

DOI: 10.4143/crt.2025.219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Seung Ah Lee und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Breast Neoplasms, Neoadjuvant Therapy, Erb-b2 Receptor Tyrosine Kinases, Brain Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This study aims to investigate the clinical characteristics, outcomes, and predictors of brain metastases in human epidermal growth factor receptor 2 (HER2)-positive advanced breast cancer patients who achieved pathological complete response (pCR) following neoadjuvant chemotherapy (NAC). This research seeks to inform surveillance strategies and optimize management for high-risk subgroups. MATERIALS AND METHODS: A retrospective analysis of 1,757 patients (2008-2022) classified them into pCR (n=914) and non-pCR (n=843) groups post-NAC. Collected data included demographics, clinical features, and metastasis parameters. Survival outcomes and brain metastasis predictors were assessed using Kaplan-Meier curves, Cox models, and logistic regression. RESULTS: Among pCR patients, brain metastases accounted for 54.2% of distant metastases, significantly affecting overall survival (p < 0.001). Median distant metastasis-free survival was shorter for brain metastases (13.4 months) compared to extracranial metastases (31.1 months) in the pCR group (p=0.005). Positive supraclavicular node (SCN) fine needle aspiration (FNA) and clinical N3 (cN3) category were the strongest predictors of brain metastases (SCN FNA: odds ratio [OR], 12.9; p < 0.001; cN3: OR, 12.1; p < 0.001). Multivariable Cox regression analysis revealed that positive SCN FNA and cN3 category were strong predictors of reduced distant metastasis-free survival (SCN FNA: hazard ratio, 2.5; 95% confidence interval [CI], 1.3 to 3.6; p < 0.001; cN3: hazard ratio, 11.3; 95% CI, 4.9 to 33.0; p < 0.001). CONCLUSION: This study highlights the challenges of brain metastases in HER2-positive pCR patients, emphasizing the need for tailored therapeutic strategies and enhanced surveillance. High lymph node burden prior to NAC is a significant factor in risk assessment. Therefore, it may be advisable to recommend post-surgery surveillance for high-risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsNeoadjuvant TherapyErb-b2 Receptor Tyrosine KinasesBrain NeoplasmsLymph NodesHumansFemalePathologic Complete ResponseRetrospective StudiesMiddle AgedAdultLymphatic MetastasisAgedPrognosis

Stichwörter der Autor:innen

Brain metastasisComplete responseHER2-positive breast cancerNeoadjuvant therapy

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, human

Autor:innen und Institutionen

  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Hematology Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Department of Radiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Breast Surgery, Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. jeongeon.lee@samsung.com.

Zitieren

APA

Lee, S. A., Kim, K. J., Woen, D. Y., Lee, S. M., Oh, K., Lee, C. E., Park, W. K., Yoo, J. W., Shin, D. S., Ryu, J. M., Lee, S. K., Chae, B. J., Yu, J., Kim, S. W., Nam, S. J., Kim, J. Y., Park, Y. H., Ko, E. Y., Ko, E. S., & Lee, J. E. (2025). Impact of High Lymph Node Burden on Brain Metastases in Patients Who Achieved Pathological Complete Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Cancer Research and Treatment. https://doi.org/10.4143/crt.2025.219

Vancouver

Lee SA, Kim KJ, Woen DY, Lee SM, Oh K, Lee CE, et al. Impact of High Lymph Node Burden on Brain Metastases in Patients Who Achieved Pathological Complete Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer. Cancer Research and Treatment. 2025. doi:10.4143/crt.2025.219

BibTeX
@article{Lee2025,
  author = {Lee, Seung Ah and Kim, Ki Jo and Woen, Do Youn and Lee, Su Min and Oh, Kawon and Lee, Cho Eun and Park, Woong Ki and Yoo, Ji Won and Shin, Dong Seung and Ryu, Jai Min and Lee, Se Kyung and Chae, Byung Joo and Yu, Jonghan and Kim, Seok Won and Nam, Seok Jin and Kim, Ji-Yeon and Park, Yeon Hee and Ko, Eun Young and Ko, Eun Sook and Lee, Jeong Eon},
  title = {Impact of High Lymph Node Burden on Brain Metastases in Patients Who Achieved Pathological Complete Response after Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer},
  journal = {Cancer Research and Treatment},
  year = {2025},
  doi = {10.4143/crt.2025.219}
}
Kostenlos starten →